Profil
Jas Uppal worked as Director & Head-Global Emerging Markets at Biogen, Inc., Manager-Worldwide Regulatory Affairs at PAREXEL International Corp., and Chief Regulatory & Quality Officer at Gamida Cell Ltd. She also served as VP-Regulatory Affairs & Pharmacovigilance at Karyopharm Therapeutics, Inc. from 2015 to 2017 and as Vice President & Global Head-Regulatory Affairs at Ipsen Biopharmaceuticals, Inc. from 2017 to 2019.
Uppal holds a doctorate degree from King's College London and an undergraduate degree from Queen Mary University of London.
Anciens postes connus de Jas Uppal
| Sociétés | Poste | Fin |
|---|---|---|
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Corporate Officer/Principal | 01/01/2019 |
| KARYOPHARM THERAPEUTICS INC. | Conseiller Juridique Général | 01/01/2017 |
| GAMIDA CELL LTD. | Conseiller Juridique Général | - |
| BIOGEN INC. | Directeur/Membre du Conseil | - |
| PAREXEL INTERNATIONAL CORPORATION | Conseiller Juridique Général | - |
Formation de Jas Uppal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Karyopharm Therapeutics, Inc.
Karyopharm Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation | Health Technology |
Queen Mary University of London
Queen Mary University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
















